Full-term infant. Blood 1987, 70:165?72. 10. Andrew M, Vegh P, Johnston M, Bowker J, Ofosu F, Mitchell L: Maturation of your hemostatic system for the duration of childhood. Blood 1992, 80:1998?005. 11. Rau JC, Beaulieu LM, Huntington JA, Church FC: Serpins in thrombosis, hemostasis and fibrinolysis. J Thromb Haemost 2007, 5(Suppl 1):102?15. 12. Amrani DL, Mosesson MW, Koide T: Proof that chicken antithrombin III is often a developmentally regulated glycoprotein synthesized by hepatocytes. Biochim Biophys Acta 1985, 847:324?34. 13. Niessen RW, Lamping RJ, Peters M, Lamers WH, Sturk A: Fetal and neonatal improvement of antithrombin III plasma activity and liver messenger RNA levels in sheep. Pediatr Res 1996, 39:685?91. 14. Ishiguro K, Kojima T, Kadomatsu K, Nakayama Y, Takagi A, Suzuki M, Takeda N, Ito M, Yamamoto K, Matsushita T, Kusugami K, Muramatsu T, Saito H: Complete antithrombin deficiency in mice final results in embryonic lethality. J Clin Invest 2000, 106:873?78. 15. Hagiwara S, Iwasaka H, Shingu C, Matsumoto S, Uchida T, Noguchi T: High-dose antithrombin III prevents heat stroke by attenuating systemic inflammation in rats. Inflamm Res 2010, 59:511?18. 16. Larsson H, Akerud P, Nordling K, Raub-Segall E, Claesson-Welsh L, Bjork I: A novel anti-angiogenic kind of antithrombin with retained proteinase binding ability and heparin affinity. J Biol Chem 2001, 276:11996?2002.17. Guerrero JA, Teruel R, Martinez C, Arcas I, Martinez-Martinez I, de la MorenaBarrio ME, Vicente V, Corral J: Protective part of antithrombin in mouse models of liver injury. J Hepatol 2012, 57:980?86. 18. Manco-Johnson MJ, Jacobson LJ, Hacker MR, Townsend SF, Murphy J, Hay W Jr: Development of coagulation regulatory proteins inside the fetal and neonatal lamb. Pediatr Res 2002, 52:580?88. 19. McCoy AJ, Pei XY, Skinner R, Abrahams JP, Carrell RW: Structure of beta-antithrombin as well as the impact of glycosylation on antithrombin’s heparin affinity and activity. J Mol Biol 2003, 326:823?33. 20. Ellies LG, Ditto D, Levy GG, Wahrenbrock M, Ginsburg D, Varki A, Le DT, Marth JD: Sialyltransferase ST3Gal-IV operates as a dominant modifier of hemostasis by concealing asialoglycoprotein receptor ligands. Proc Natl Acad Sci USA 2002, 99:10042?0047. 21. Fan B, Crews BC, Turko IV, Choay J, Zettlmeissl G, Gettins P: Heterogeneity of recombinant human antithrombin III expressed in child hamster kidney cells. Effect of glycosylation differences on heparin binding and structure.131726-65-3 Order J Biol Chem 1993, 268:17588?7596. 22. Zhang L, Hammell M, Kudlow BA, Ambros V, Han M: Systematic evaluation of dynamic miRNA-target interactions throughout C.Buy2-Chloropyrimidine-4,5-diamine elegans improvement.PMID:23800738 Development 2009, 136:3043?055. 23. Ashwell G, Harford J: Carbohydrate-specific receptors on the liver. Annu Rev Biochem 1982, 51:531?54. 24. Kahai S, Lee SC, Lee DY, Yang J, Li M, Wang CH, Jiang Z, Zhang Y, Peng C, Yang BB: MicroRNA miR-378 regulates nephronectin expression modulating osteoblast differentiation by targeting GalNT-7. PLoS One 2009, four:e7535. 25. Guttilla IK, White BA: Coordinate regulation of FOXO1 by miR-27a, miR-96, and miR-182 in breast cancer cells. J Biol Chem 2009, 284:23204?3216. 26. Wan HY, Guo LM, Liu T, Liu M, Li X, Tang H: Regulation from the transcription factor NF-kappaB1 by microRNA-9 in human gastric adenocarcinoma. Mol Cancer 2010, 9:16. 27. Raja SM, Chhablani N, Swanson R, Thompson E, Laffan M, Lane DA, Olson ST: Deletion of P1 arginine within a novel antithrombin variant (antithrombin London) abolishes inhibitory activity but enhanc.